Skyscape Web Viewer : Targeted Cancer Therapy A Handbook for Nurses : Main Index

View All
Antibody-dependent cellularcytotoxicity Antiangiogenic Drug Therapy Chapter 2. Targeted Cancer Therapy: External and Internal Signaling Pathway Targets Glossary Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Monoclonal Antibodies
Antibody-drug conjugate, HER2
Anticancer therapies, cancer cell death and Application Of The Hallmarks Of Cancer Invasion and Metastasis
Antidiarrheal medication Epigenetic Abnormalities (Dna Methyltransferase and Histone Deacetylase) Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways) Nursing Considerations and Drug Information Protein Dynamics: Heat Shock Proteins and Ubiquitin - Proteasome Inhibitors
Antigens Application Of The Hallmarks Of Cancer Epigenetic Abnormalities (Dna Methyltransferase and Histone Deacetylase) Glossary Monoclonal Antibodies Targeting Angiogenesis
Antimicrobials, for osteonecrosis of the jaw
Apaf-1 adaptor
APC gene
Apo2L/TRAIL References (Chapter 4) Targeting Apoptosis
Apomab References (Chapter 4) Targeting Apoptosis
Apoptosis
Apoptotic pathways
ARBs,
Aredia,
Arf
Aromatase inhibitors, bone loss and Bone Metastasis References (Chapter 4)
Arterial thromboembolic events
ASA404 Antiangiogenic Drug Therapy Hypoxia-Inducible Factor, Mtor, and Angiogenesis References (Chapter 3)
ASCO,
Aspartate aminotransferase (AST), elevated, temsirolimus and
ATE,
ATM gene
ATP,
ATRA,
Aurora A Application Of The Hallmarks Of Cancer function of Glossary Mitotic Kinase Inhibitors role of, within Aurora family
Aurora B Application Of The Hallmarks Of Cancer function of Glossary Mitotic Kinase Inhibitors role of, within Aurora family
Aurora C Application Of The Hallmarks Of Cancer function of Mitotic Kinase Inhibitors
Aurora family
Aurora kinases Application Of The Hallmarks Of Cancer defined Glossary Mitotic Kinase Inhibitors References (Chapter 4) targeting, drugs being tested for
Autocrine loop Hepatocyte Growth Factor (Hgf/C-Met) Receptor Pathway Targets Membrane-Bound Receptor Kinases (E.g., Egfr, Her2, Hgf/C-Met, Igfr Pathways)